Rare diseases
Investigational molecules
Locations
Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
CzechiaStudy of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy
CzechiaStudy of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels
CzechiaLong‑Term Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease
CzechiaPrevention of radiation-induced salivary gland damage using botulinum toxin type A in patients with head and neck cancer
CzechiaSafety and Efficacy of VX-828, Deutivacaftor, and Tezacaftor in Adults with Cystic Fibrosis
CzechiaEvaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients
CzechiaELV001 for Active Rheumatoid Arthritis in Patients with Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition
CzechiaStudy of human normal immunoglobulin to prevent major infections in patients with hypogammaglobulinemia and autoimmune/rheumatic disease on B‑cell depletion therapy
CzechiaStudy of asciminib, dexamethasone, blinatumomab, and vincristine sulfate in children and young adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
CzechiaA study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis
CzechiaPhase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
